Stock News & Analysis

SK Hynix boasts a 44% net margin and fortress balance sheet, while Monday.com's 27% revenue growth comes with a hefty stock-based compensation burden.

This sale reduced a director's direct equity holdings by 23%, leaving him with 30,702 shares worth $912,770.

Is Cava the next big thing in fast-casual dining? Join us as we explore its strengths, management, and financials to see if this stock is worth your investment.

They are way more than just GLP-1 stocks.

This automatic sell-to-cover execution tied to equity award vesting reduced an executive's direct holdings by 3%.

Amazon's $77.7 billion net income and 10.8% margin showcase profitability at scale, while StubHub's $191 million free cash flow points to a path back from recent losses.

Crypto prices dropped after declines in consumer confidence and retail sales raised economic concerns today, Aug. 14, 2026.

Automatic equity vesting triggered a non-discretionary sale valued at $137,520, reducing McGurn's direct stake by 12% while he retains 120,811 shares worth $1 million.

The company's major plans for its data center future suffered a setback.

Investors are mining below the headline numbers, and they dig what they discovered.

Some of this money doesn't have to be paid back for 40 years. The servers the search giant is buying are depreciated over about six years.

On Aug. 14, 2026, disappointing retail spending and consumer confidence data pulled markets back from record highs, with chipmakers leading declines.

On Aug. 14, 2026, analyst support helped the stock climb, adding to a two-week rally.

One company is generating substantial free cash flow and returning billions to shareholders. The other is still working toward its first profitable year. The risk profiles could not be more different.

AppLovin commands a 30-fold revenue advantage, yet SoundHound's growth rate tells a different story about which trajectory matters more.

One company is a profitable, growing leader in cybersecurity. The other is an early-stage quantum computing bet with enormous long-term potential but a long road ahead.

The drugmaker should significantly mitigate its most important risk as it develops new products.

Arista commands networking with zero debt and 39% margins, while AppLovin's AI platform grew 70% with a lower valuation, but each carries distinct risks.

One operates a restructuring retail network with negative free cash flow; the other burns cash on pre-revenue aviation tech backed by Toyota and Delta.

Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.